Depressive symptom clusters as predictors of 6-year increases in insulin resistance: Data from the Pittsburgh healthy heart project

Psychosomatic Medicine

Volumn 76, Issue 5, 2014, Pages 363-369

  Khambaty, Tasneem ^a   Stewart, Jesse C ^a   Muldoon, Matthew F ^b   Kamarck, Thomas W ^b  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

depression; homeostatic model of assessment; insulin resistance; prospective study; symptom clusters; Type 2 diabetes

Indexed keywords

GLUCOSE; INSULIN; C REACTIVE PROTEIN; IL6 PROTEIN, HUMAN; INTERLEUKIN 6;

ADULT; AGED; ANXIETY; ARTICLE; BECK DEPRESSION INVENTORY; BODY MASS; DEPRESSION; FEMALE; FOLLOW UP; HOSTILITY; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; BLOOD; DIABETES MELLITUS, TYPE 2; DRINKING BEHAVIOR; EATING DISORDERS; FATIGUE; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; PROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS; SMOKING; SOCIOECONOMICS;

AGED; ALCOHOL DRINKING; ANXIETY; BODY MASS INDEX; C-REACTIVE PROTEIN; DEPRESSION; DIABETES MELLITUS, TYPE 2; EATING DISORDERS; FATIGUE; FEMALE; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-6; MALE; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS; SMOKING; SOCIOECONOMIC FACTORS;

EID: 84903266939     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0000000000000063     Document Type: Article

References (57)

1. Rustad JK, Musselman DL, Nemeroff CB. The relationship of depression and diabetes: Pathophysiological and treatment implications. Psychoneuroendocrinology 2011;36:1276-86.
2. Roy T, Lloyd CE. Epidemiology of depression and diabetes: A systematic review. J Affect Disord 2012;142:S8-21.
3. Renn BN, Feliciano L, Segal DL. The bidirectional relationship of depression and diabetes: A systematic review. Clin Psychol Rev 2011;31:1239-46.
4. Knol M, Twisk J, Beekman A, Heine R, Snoek F, Pouwer F. Depression as a risk factor for the onset of Tyoe 2 diabetes mellitus. A meta-analysis. Diabetologia 2006;49:837-45.
5. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and Type 2 diabetes over the lifespan. Diabetes Care 2008;31:2383-90.
6. Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A. Depression and the risk for cardiovascular diseases: Systematic review and meta analysis. Int J Geriatr Psychiatry 2007;22:613-26.
7. Nouwen A, Nefs G, Caramlau I, Connock M,Winkley K, Lloyd CE, Peyrot M, Pouwer F. Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes a systematic reviewand metaanalysis of the European Depression in Diabetes (EDID) research consortium. Diabetes Care 2011;34:752-62.
8. Golden SH. A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus. Curr Diab Rev 2007;3:252-9.
9. Kiecolt-Glaser JK, Glaser R. Depression and immune functionVcentral pathways to morbidity and mortality. J Psychosom Res 2002;53:873-6.
10. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes Types 1 and 2: Epidemiology, biology, and treatment. Biol Psychiatry 2003;54:317-29.
11. Silva N, Atlantis E, Ismail K. A review of the association between depression and insulin resistance: Pitfalls of secondary analyses or a promising new approach to prevention of Type 2 diabetes? Curr Psychiatry Rep 2012;14:1-7.
12. Kan C, Silva N, Golden SH, Rajala U, Timonen M, Stahl D, Ismail K. A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care 2013;36:480-9.
13. Everson-Rose SA,MeyerPM, Powell LH, PandeyD, Torréns JI,KravitzHM, Bromberger JT,Matthews KA. Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care 2004;27:2856-62.
14. Stewart JC, Zielke DJ, Hawkins MA, Williams DR, Carnethon MR, Knox SS, Matthews KA. Depressive symptom clusters and 5-year incidence of coronary artery calcification: Clinical perspective. The Coronary Artery Risk Development in Young Adults Study. Circulation 2012;126:410-7.
15. Carney RM, Freedland KE. Are somatic symptoms of depression better predictors of cardiac events than cognitive symptoms in coronary heart disease? Psychosom Med 2012;74:33-8.
16. Davidson KW, Rieckmann N, Rapp MA. Definitions and distinctions among depressive syndromes and symptoms: Implications for a better understanding of the depressionYcardiovascular disease association. Psychosom Med 2005;67:S6-9.
17. KamarckTW, Muldoon MF, Shiffman SS, Sutton-Tyrrell K. Experiences of demand and control during daily life are predictors of carotid atherosclerotic progression among healthy men. Health Psychol 2007;26:324.
18. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: Insulin resistance and A-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
19. Clark LA, Watson D. Tripartite model of anxiety and depression: Psychometric evidence and taxonomic implications. J Abnorm Psychol 1991; 100:316-36.
20. Raynor DA, Pogue-Geile MF, Kamarck TW, McCaffery JM, Manuck SB. Covariation of psychosocial characteristics associated with cardiovascular disease: Genetic and environmental influences. Psychosom Med 2002;64: 191-203.
21. Felsten G. Hostility, stress and symptoms of depression. Pers Indiv Differ 1996;21:461-7.
22. Zhang JP, Niaura R, Dyer JR, Shen BJ, Todaro JF, McCaffery JM, Spiro A, Ward KD. Hostility and urine norepinephrine interact to predict insulin resistance: The VA Normative Aging study. Psychosom Med 2006;68: 718-26.
23. Narita K, Murata T, Hamada T, Kosaka H, Sudo S, Mizukami K, Yoshida H, Wada Y., Associations between trait anxiety, insulin resistance, and atherosclerosis in the elderly: A pilot cross-sectional study. Psychoneuroendocrinology 2008;33:305-12.
24. Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer D. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatry 2001;158:848-56.
25. Howren MB, Lamkin DM, Suls J. Associations of depression with Creactive protein, IL-1, and IL-6: A meta-analysis. Psychosom Med 2009; 71:171-86.
26. Stewart JC, Janicki DL, Muldoon MF, Sutton-Tyrrell K, Kamarck TW. Negative emotions and 3-year progression of subclinical atherosclerosis. Arch Gen Psychiatry 2007;64:225.
27. Kline RB. Principles and Practice of Structural Equation Modeling. 3rd ed. New York: Guilford Press; 2010.
28. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory. 2nd ed. San Antonio, TX: The Psychological Corporation.; 1996;1:82.
29. Dozois DJA, Dobson KS, Ahnberg JL. A psychometric evaluation of the Beck Depression Inventory-II. Psychol Assess 1998;10:83.
30. Viljoen JL, Iverson GL, Griffiths S, Woodward TS. Factor structure of the Beck Depression Inventory-II in a medical outpatient sample. J Clin Psychol Med Settings 2003;10:289-91.
31. Stewart JC, Rand KL, Muldoon MF, Kamarck TW. A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav Immun 2009;23:936-44.
32. Stewart JC, Fitzgerald GJ, Kamarck TW. Hostility now, depression later? Longitudinal associations among emotional risk factors for coronary artery disease. Ann Behav Med 2010;39:258-66.
33. Bondar RJL, Mead DC. Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum. Clin Chem 1974;20:586-90.
34. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63.
35. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-95.
36. Wallace T, Matthews D. The assessment of insulin resistance in man. Diabet Med 2002;19:527-34.
37. Steer RA, Beck AT. Beck Anxiety Inventory. In: Zalequett CP, Wood RJ, editors. Evaluating Stress: A Book of Resources. Lanham, MD: Scarecrow Press, Inc.; 1997:23-40.
38. Beck A, Steer R. Manual for the Beck Anxiety Inventory. San Antonio, TX: Psychological Corporation; 1990.
39. Barefoot JC, Dodge KA, Peterson BL, Dahlstrom WG, Williams RB. The Cook-Medley hostility scale: Item content and ability to predict survival. Psychosom Med 1989;51:46-57.
40. Barefoot JC, Dahlstrom WG, Williams RB. Hostility, CHD incidence, and total mortality: A 25-year follow-up study of 255 physicians. Psychosom Med 1983;45:59-63.
41. Shekelle RB, Gale M, Ostfeld AM, Paul O. Hostility, risk of coronary heart disease, and mortality. Psychosom Med 1983;45:109-14.
42. Smith TW, Frohm KD. What's so unhealthy about hostility? Construct validity and psychosocial correlates of the Cook and Medley Ho Scale. Health Psychol 1985;4:503.
43. Garg R, Wagener DK, Madans JH. Alcohol consumption and risk of ischemic heart disease in women. Arch Intern Med 1993;153:1211.
44. Paffenbarger RS, WING AL, HYDE RT. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol 1978;108:161-75.
45. Buysse DJ, Reynolds III CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
46. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL. Markers of inflammation and cardiovascular disease application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
47. Preacher KJ, Leonardelli G. Calculation for the Sobel test: An interactive calculation tool for mediation tests. Available at: http://www.people.ku.edu/~preacher/sobel/sobel.htm. Accessed October 25, 2010.
48. Aroian LA. The probability function of the product of two normally distributed variables. Ann Math Stat 1944/1947;18:256-71.
49. Lawlor DA, Ben-Shlomo Y, Ebrahim S, Smith GD, Stansfeld SA, Yarnell JW, Gallacher JE. Insulin resistance and depressive symptoms in middle aged men: Findings from the Caerphilly prospective cohort study. BMJ 2005;330:705.
50. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010;72:219-46.
51. Vreeburg SA, Hoogendijk WJ, van Pelt J, DeRijk RH, Verhagen J, van Dyck R, Smit JH, Zitman FG, Penninx BW. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: Results from a large cohort study. Arch Gen Psychiatry 2009;66:617.
52. Carney RM, Freedland KE, Veith RC. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med 2005;67:S29-33.
53. Duivis HE, Vogelzangs N, Kupper N, de Jonge P, Penninx BW. Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: Findings from the Netherlands Study of Depression and Anxiety (NESDA). Psychoneuroendocrinology 2013;38:1573-85.
54. Morgenstern M, Wang J, Beatty N, Batemarco T, Sica A, Greenberg H. Obstructive sleep apnea: An unexpected cause of insulin resistance and diabetes. Endocrinol Metab Clin N Am 2014;43:187-204.
55. Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E. Sleep loss: A novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 2005;99:2008-19.
56. Kim Y, Pilkonis PA, Frank E, Thase ME, Reynolds CF. Differential functioning of the Beck depression inventory in late-life patients: Use of item response theory. Psychol Aging 2002;17:379.
57. Talbot F, Nouwen A. A review of the relationship between depression and diabetes in adults: Is there a link? Diabetes Care 2000;23:1556-62.